Ipca Laboratories Limited (IPCALAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 406.17B |
| Enterprise Value | 408.61B |
| P/E Ratio | 34.37 |
| PEG Ratio | 0.5 |
| Price/Sales Ratio | 4.6 |
| Price/Book Ratio | 5.55 |
| Enterprise/Revenue | 4.65 |
| Enterprise/EBITDA | 19.95 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 96.46B |
| Revenue/Share | 413.05 |
| Gross Profit | 61.83B |
| EBITDA | 19.62B |
| Net Income | 11.41B |
| Diluted EPS | 44.98 |
Balance Sheet
| Total Cash | 11.48B |
| Total Cash/Share | 45.26 |
| Total Debt | 7.53B |
| Total Debt/Equity | 0.09 |
| Current Ratio | 2.88 |
| Book Value Per Share | 401.01 |
Price History
| 52-Week Change | 41.67 |
| 52-Week High | 2,038 |
| 52-Week Low | 1,293.9 |
| Moving Average 50 Days | 1,941.24 |
| Moving Average 200 Days | 1,705.02 |
Statistics
| Average Volume | 410,147 |
| Shares Outstanding | 253.7M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6 |
| Trailing Annual Dividend Yield | 0.32 |
| Payout Ratio | 0.04 |
| Last Split Factor | 2:1 |
| Last Split Date | January 10, 2022 |
AD
